Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
The electronic medicines compendium (emc) no longer publishes a Summary of Product Characteristics for this product, which usually means it is no longer marketed in the UK. The patient leaflet below is kept for reference, but the product may not be available.
If you were prescribed this medicine, other products containing Chloramphenicol may still be available. Do not stop your treatment — ask your pharmacist or GP what to use instead.
for
Chloramphenicol capsules contain chloramphenicol which is an antibiotic for specific uses. They are used for treatment of typhoid fever and other dangerous infections where other antibiotics are not effective.
e Chloramphenicol capsules
Do not take Chloramphenicol capsules:
1
Some medicines may be affected by chloramphenicol or they may affect how well chloramphenicol will work. Tell your doctor or pharmacist if you are taking:
Chloramphenicol Capsules
Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure. Swallow the capsules whole with a drink of water. Adults and elderly The usual dose is 500 mg (2 capsules) every 6 hours or 50 mg per kg body weight daily in divided doses. Blood tests may be carried out to check the level of chloramphenicol in your body and to make sure your blood is functioning properly, as chloramphenicol can damage blood cells. Use in children This medicine is not suitable for children. 75/L/f/7
2
If you take more Chloramphenicol capsules than you should It is likely that you will be taking these capsules in hospital and, therefore, it is unlikely that you will overdose. However, if you do take more capsules than you should: 1. Tell your doctor, pharmacist, nurse or nearest hospital casualty department immediately. 2. Take the container and any remaining capsules with you so that people can see what you have taken. 3. Do this even if you feel well. If you forget to take Chloramphenicol capsules If you forget to take a dose take it as soon as you remember, but if it is almost time for your next dose, skip the missed dose and continue as usual. Do not take a double dose to make up for a forgotten dose. Tell the doctor if you miss a dose. If you stop taking Chloramphenicol capsules Do not stop just because you feel better. If you stop too soon, the infection may come back. Keep taking your capsules until the prescribed course is finished. If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.
4. Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them. STOP taking the capsules and seek medical help immediately if you have any of the following allergic reactions:
not listed in this leaflet. You can also report side effects directly via the Yellow Card 75/L/f/7 3
Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.
Chloramphenicol Capsules
Keep this medicine out of the sight and reach of children.
Do not take after the expiry date which is stated on the label and on the carton after EXP. The expiry date refers to the last day of that month. Store in a cool dry place in the original package. Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
What Chloramphenicol Capsules contain
75/L/f/7
4
Chloramphenicol Capsules BP 250 mg comes as capsule containing 250mg. Always follow the dose your doctor or pharmacist has given you, and read the leaflet that comes with the medicine.
The active substance in Chloramphenicol Capsules BP 250 mg is chloramphenicol.
This leaflet reproduces the patient information leaflet approved for Chloramphenicol Capsules BP 250 mg, as published on the electronic medicines compendium (emc). The version printed inside your medicine’s packaging is the one that applies to you.
Whether a medicine is available over the counter or on prescription only depends on its licence. Check the leaflet, or ask your pharmacist — they can tell you straight away.
The text above reproduces the patient information leaflet approved for this medicine, restructured for easier reading.
Typhoid fever and life-threatening infections, particularly those caused by Haemophilus influenzae where other antibiotics will not suffice.
Posology
Adults and elderly
The normal dose is 50 mg/kg body weight daily in 4 divided doses. For severe infections (meningitis, septicaemia) this dose may be doubled initially, but it must be reduced as soon as clinically practical.
Paediatric population
The safety and efficacy of Chloramphenicol Capsules BP 250 mg have not yet been established in children.
Method of administration
For oral administration.
Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Chloramphenicol is contra-indicated in prophylaxis or treatment of minor infections; during active immunisation; and in porphyria patients.
Chloramphenicol is contra-indicated in patients taking drugs liable to depress bone marrow function (see section 4.5).
Chloramphenicol must not be used in breast-feeding mothers and during pregnancy or labour, due to a risk of foetal/ infant damage (Gray Baby syndrome).
Chloramphenicol should only be used if other treatments are ineffective and its use should always be carefully monitored.
Dose reduction and plasma level monitoring may be required in patients with hepatic or renal impairment; in the elderly; and in patients concurrently treated with interacting drugs (see section 4.5).
Periodic blood testing should be conducted during prolonged or repeated treatment. Chloramphenicol should be discontinued if a significant detrimental effect is seen.
This medicine contains less than 1 mmol sodium (23 mg) per capsule, that is to say essentially 'sodium-free'.
Warfarin, phenytoin, sulphonylureas and tolbutamide
Chloramphenicol prolongs the elimination, increasing the blood levels, of drugs including warfarin, phenytoin, sulphonylureas, tolbutamide.
Anticonvulsants and anticoagulants
Doses of anticonvulsants and anticoagulants may need to be adjusted if given concurrently.
Penicillins and rifampicin
Complex effects (including reduced / increased plasma levels) requiring monitoring of chloramphenicol plasma levels have been reported with co-administration of penicillins and rifampicin.
Paracetamol
Concurrent administration of paracetamol should be avoided as this prolongs chloramphenicol half-life.
Calcineurin Inhibitors (CNIs) Ciclosporin and Tacrolimus
Treatment with chloramphenicol possibly increases the plasma levels of the CNIs ciclosporin and tacrolimus.
Barbiturates
The metabolism of chloramphenicol is accelerated by barbiturates, such as phenobarbitone, leading to reduced plasma concentrations. There is a possible decrease in the metabolism of phenobarbitone with concomitant chloramphenicol administration.
Oestrogens
There is a small risk that chloramphenicol may reduce the contraceptive effect of oestrogens.
Hydroxocobalamin
Chloramphenicol reduces the response to hydroxocobalamin.
Drugs causing agranulocytosis
Chloramphenicol is contra-indicated in patients taking drugs liable to suppress bone marrow function (see section 4.3). These include:
- Carbamazapine
- Sulphonamides
- Phenylbutazone
- Penicillamine
- Cytotoxic agents
- Some antipsychotics, including clozapine and particularly depot antipsychotics
- Procainamide
- Nucleoside reverse transcriptase inhibitors
- Propylthiouracil
Pregnancy
Chloramphenicol crosses the placenta. Therefore chloramphenicol is contraindicated during pregnancy (see section 4.3).
Breast-feeding
Chloramphenicol is excreted in breast milk. Therefore chloramphenicol is contraindicated during breast-feeding (see section 4.3).
Fertility
No human data on the effects of chloramphenicol on fertility is available.
Chloramphenicol Capsules BP 250 mg have no or negligible influence on the ability to drive and use machines.
Adverse reactions are listed below by system organ class and frequency. Frequencies are defined as follows: very common (≥ 1/10), common (≥ 1/100 to < 1/10), uncommon (≥ 1/1,000 to < 1/100), rare (≥ 1/10,000 to < 1/1,000), very rare (< 1/100,000), not known (cannot be estimated from the available data).
Blood and lymphatic disorders
Rare:
(i) A reversible dose related bone marrow depression.
(ii) An irreversible aplastic anaemia
Not known:
Increase in bleeding time.
Immune system disorders
Not known:
Hypersensitivity reactions including allergic skin reactions.
Eye disorders
Not known:
Optic neuritis leading to blindness.
Ear and labyrinth disorders
Not known:
Ototoxicity.
Vascular disorders
Not known:
Acidotic cardiovascular collapse.
Gastrointestinal disorders
Not known:
Nausea, vomiting, glossitis, stomatitis, diarrhoea, enterocolitis.
Pregnancy, puerperium and perinatal conditions
Not known:
“Gray” syndrome, particularly in the newborn, which appears to be related to excessively high plasma levels. The Gray baby syndrome consists of abdominal distension, pallid cyanosis, vomiting, progressing to vasomotor collapse, irregular respiration and death within a few hours of onset of symptoms. (These symptoms are thought to be dose related and rapid clearance of chloramphenicol has been associated with recovery).
Reporting of suspected adverse reactions
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
Where adverse effects show signs of developing administration must be stopped immediately and treatment is mainly supportive. If an allergy develops, oral antihistamines may be used. In severe overdosage e.g. Gray Baby Syndrome, there is a need for a rapid reduction in plasma levels and it has been reported that resin haemoperfusion (XAD-4) substantially increases Chloramphenicol clearance.
Medicines sold in Romania with the same active substance: Cunoscut în România ca
Same active substance. The strength, the form and whether you need a prescription can differ. Always ask a pharmacist before you switch. Romanian medicines in the UK →
Medicines sold in Poland with the same active substance: W Polsce znany jako
⚠ Same active substance, but a different pharmaceutical form (for example a gel instead of a tablet). Not interchangeable — ask a pharmacist.
Same active substance. The strength, the form and whether you need a prescription can differ. Always ask a pharmacist before you switch. Polish medicines in the UK →
Ask anything about Chloramphenicol Capsules BP 250 mg. The assistant answers only from this leaflet — if the leaflet does not cover it, it will say so. It does not give medical advice.
Answers come from the patient leaflet published on the electronic medicines compendium (emc). They are not medical advice. Ask a pharmacist or your GP if you are unsure. For urgent help call NHS 111, or 999 in an emergency.
We use essential cookies to make the site work. We would also like to set optional cookies to understand how the site is used, so we can improve it. We will not set optional cookies unless you accept. See our cookie policy and privacy policy.